Evidence map›Paper›PMID 23982146›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway.

Seung-Eon Roh, Jung A Woo, Madepalli K Lakshmana, Courtney Uhlar, Vinishaa Ankala, Taylor Boggess, Tian Liu, Yun-Hwa Hong, Inhee Mook-Jung, Sang Jeong Kim and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Cofilin(s) and Mitochondria: Function Beyond Actin Dynamics.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Regulation of Mitochondrial Function by the Actin Cytoskeleton.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Scorpins in the DNA Damage Response.International journal of molecular sciences · 2018
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Seung-Eon Roh1Department of Molecular Medicine, USF Health Byrd Institute, 4001 E. Fletcher Ave., Tampa, FL 33613, USA. dkang@health.usf.edu.
Jung A Woo
Madepalli K Lakshmana
Courtney Uhlar
Vinishaa Ankala
Taylor Boggess
Tian Liu
Yun-Hwa Hong
Inhee Mook-Jung
Sang Jeong Kim
David E Kang
New Generation University College · ETUniversity of South Florida · USSeoul National University · KRNational University College · PRTorrey Pines Institute For Molecular Studies · USUSF Health Byrd Alzheimer's Institute · US

Funding

Novel Mechanisms of RanBP9 in APP PathogenesisR01AG033055 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E · 2009 to 2012
$1.2M
LRP/RanBP9 Pathway in Alzheiimer's Disease PathogenesisK02AG031920 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E · 2009 to 2011
$341k
NIA NIH HHS 1K02AG031920NIA NIH HHS 1R01AG033055NIA NIH HHS K02 AG031920NIA NIH HHS R01 AG033055
6 · The paper itself

Abstract

Mitochondrial dysfunction and synaptic damage are important features of Alzheimer's disease (AD) associated with amyloid β (Aβ) and tau. We reported previously that the scaffolding protein RanBP9, which is overall increased in brains of patients with AD and in mutant APP transgenic mice, simultaneously promotes Aβ generation and focal adhesion disruption by accelerating the endocytosis of APP and β1-integrin, respectively. Moreover, RanBP9 induces neurodegeneration in vitro and in vivo and mediates Aβ-induced neurotoxicity. Here we show in primary hippocampal neurons that RanBP9 potentiates Aβ-induced reactive oxygen species (ROS) overproduction, apoptosis, and calcium deregulation. Analyses of calcium-handling measures demonstrate that RanBP9 selectively delays the clearance of cytosolic Ca(2+) mediated by the mitochondrial calcium uniporter through a process involving the translocation of cofilin into mitochondria and oxidative mechanisms. Further, RanBP9 retards the anterograde axonal transport of mitochondria in primary neurons and decreases synaptic mitochondrial activity in brain. These data indicate that RanBP9, cofilin, and Aβ mimic and potentiate each other to produce mitochondrial dysfunction, ROS overproduction, and calcium deregulation, which leads to neurodegenerative changes reminiscent of those seen in AD.

Indexed as

Calcium SignalingActin Depolymerizing FactorsAdaptor Proteins, Signal TransducingAmyloid beta-PeptidesAnimalsApoptosisAxonal TransportCalciumCalcium ChannelsCytoskeletal ProteinsHippocampusMembrane Potential, MitochondrialMiceMitochondriaNeuronsNuclear ProteinsActin Depolymerizing FactorsAdaptor Proteins, Signal TransducingAmyloid beta-Peptidesamyloid beta-protein (1-42)CalciumCalcium ChannelsCytoskeletal Proteinsmitochondrial calcium uniporterNuclear ProteinsPeptide FragmentsRan binding protein 9Reactive Oxygen Speciesamyloidaxonal transportMTTsynapse

Identifiers

PMID23982146
PMCPMC3834781
OpenAlexW2143868008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.